162 related articles for article (PubMed ID: 12510948)
1. 19. Male breast cancer: aetiology, genetics and clinical management.
Tischkowitz MD; Hodgson SV; Fentiman IS
Int J Clin Pract; 2002 Dec; 56(10):750-4. PubMed ID: 12510948
[TBL] [Abstract][Full Text] [Related]
2. Male breast cancer: a special therapeutic problem. Anything new? (Review).
Gennari R; Curigliano G; Jereczek-Fossa BA; Zurrida S; Renne G; Intra M; Galimberti V; Luini A; Orecchia R; Viale G; Goldhrisch A; Veronesi U
Int J Oncol; 2004 Mar; 24(3):663-70. PubMed ID: 14767551
[TBL] [Abstract][Full Text] [Related]
3. Male breast cancer.
Ottini L; Palli D; Rizzo S; Federico M; Bazan V; Russo A
Crit Rev Oncol Hematol; 2010 Feb; 73(2):141-55. PubMed ID: 19427229
[TBL] [Abstract][Full Text] [Related]
4. Male breast cancer.
Reis LO; Dias FG; Castro MA; Ferreira U
Aging Male; 2011 Jun; 14(2):99-109. PubMed ID: 21204612
[TBL] [Abstract][Full Text] [Related]
5. Male breast cancer.
Gómez-Raposo C; Zambrana Tévar F; Sereno Moyano M; López Gómez M; Casado E
Cancer Treat Rev; 2010 Oct; 36(6):451-7. PubMed ID: 20193984
[TBL] [Abstract][Full Text] [Related]
6. Male breast cancer--an andrological disease: risk factors and diagnosis.
Krause W
Andrologia; 2004 Dec; 36(6):346-54. PubMed ID: 15541050
[TBL] [Abstract][Full Text] [Related]
7. Male breast cancer: a gender issue.
Nahleh Z; Girnius S
Nat Clin Pract Oncol; 2006 Aug; 3(8):428-37. PubMed ID: 16894388
[TBL] [Abstract][Full Text] [Related]
8. Male breast cancer: a review of clinical management.
Agrawal A; Ayantunde AA; Rampaul R; Robertson JF
Breast Cancer Res Treat; 2007 May; 103(1):11-21. PubMed ID: 17033919
[TBL] [Abstract][Full Text] [Related]
9. Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy.
Palli D; Falchetti M; Masala G; Lupi R; Sera F; Saieva C; D'Amico C; Ceroti M; Rizzolo P; Caligo MA; Zanna I; Ottini L
BMC Cancer; 2007 Sep; 7():170. PubMed ID: 17767707
[TBL] [Abstract][Full Text] [Related]
10. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
[TBL] [Abstract][Full Text] [Related]
11. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
[TBL] [Abstract][Full Text] [Related]
12. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
13. Male breast cancer: a case report and review of the literature.
Petrocca S; La Torre M; Cosenza G; Bocchetti T; Cavallini M; Di Stefano D; Sammartino F; Ziparo V
Chir Ital; 2005; 57(3):365-71. PubMed ID: 16231827
[TBL] [Abstract][Full Text] [Related]
14. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG
Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204
[TBL] [Abstract][Full Text] [Related]
15. Male breast cancer.
Winchester DJ
Semin Surg Oncol; 1996; 12(5):364-9. PubMed ID: 8873325
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of male breast cancer.
Weiss JR; Moysich KB; Swede H
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):20-6. PubMed ID: 15668471
[TBL] [Abstract][Full Text] [Related]
17. Can genetic testing guide treatment in breast cancer?
Tutt A; Ashworth A
Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
[TBL] [Abstract][Full Text] [Related]
18. An unusual case of advanced bilateral male breast cancer.
Bauerschmitz GJ; Karan D; Zwiefel K; Bender HG; Mohrmann S
Onkologie; 2008 Oct; 31(10):542-4. PubMed ID: 18854654
[TBL] [Abstract][Full Text] [Related]
19. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.
Brekelmans CT; Tilanus-Linthorst MM; Seynaeve C; vd Ouweland A; Menke-Pluymers MB; Bartels CC; Kriege M; van Geel AN; Burger CW; Eggermont AM; Meijers-Heijboer H; Klijn JG
Eur J Cancer; 2007 Mar; 43(5):867-76. PubMed ID: 17307353
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic treatment of male breast cancer.
Hayes TG
Expert Opin Pharmacother; 2009 Oct; 10(15):2499-510. PubMed ID: 19708850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
